I shot an email off to Auscrete,asking about the state of the company now and the future. This was there answers for what it's worth.
GLTA
Ferro
Thank you for your interest in ASCK.
Your email was received over the weekend.
You asked a lot of good questions some of which really borders on inside information, and some with no definitive answers.
I will answer the best that I can.
You mentioned “toxic funding” which in essence will become a non-event upon the adding of the land and revenue producing facility to our financials, along with actions ASCK is currently pursuing.
ASCK last year ate through approximately $400,000 in notes in about 65 days, all the while the stock appreciated 650% plus. Were you aware of that? Most are not.
When looking into the future as you referred to, all notes really pretty small when looking at a company with just one facility producing $15 million per annum.
I am not sure how the number of OTC Companies that you personally have invested that added revenue producing assets to their books, normally it sets the platform for a massive stock move upwards.
The company is already looking at a potential 2nd facility in the Southwest like New Mexico, which will be able to service Texas easily.
Are you aware that each ASCK facility can service an area up to 1,000 miles both efficiently and economically? You probably weren’t, so many investors are not aware of that fact.
There is an answer to your West Coast question.
With a 3rd facility in the future in the Southeast, once all 3 are operational with a 1,000 range of service coverage ASCK will be positioned to most of the continental USA.
And you asked how long before the company will self-fund instead of external funding solutions, that is always considered by the Board and Management on which of the two sources will lead to maximizing shareholder values. ASCK sees revenues within the 3-6 month time frame, resulting in positive cash-flow expeditiously.
The increased outstanding shares is for the Board of Directors, none of which are sellers, and it is restricted.
I feel I covered your questionsas best as possible, should any more answerable questions arise feel free to contact me directly at the number below and be sure to leave a brief message to insure a call-back.
Once again thanks for your interest and support of ASCK, as the immediate future looks to set the stage for a very exciting and profitable year in 2018 for ASCK and everyone involved/
Regards,
E. Lee Odom, Jr.
305-853-8404
EVP Business Development – ASCK
Director of IR
